Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Breast Cancer Research : BCR|September 7, 2018
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsRoberto R Rosato, Daniel Dávila-González, Dong Soon Choi, et al.The Journal of Biological Chemistry|January 13, 2010
Histone deacetylase inhibitors activate NF-kappaB in human leukemia cells through an ATM/NEMO-related pathwayRoberto R Rosato, Sarah S Kolla, Stefanie K Hock, et al.Breast Cancer Research : BCR|May 17, 2020
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXsTejaswini P Reddy, Dong S Choi, Ann C Anselme, et al.Cancer Research|April 3, 2004
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cellsSonia C Maggio, Roberto R Rosato, Lora B Kramer, et al.Experimental Hematology|December 14, 2004
Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrionL Andrew Bouton, Carlos D Ramirez, Daniel P Bailey, et al.Communications Biology|October 23, 2020
Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSAMaria Celeste Varela, Melanie Roch, Agustina Taglialegna, et al.Breast Cancer Research : BCR|May 22, 2020
Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancerLori J Goldstein, Raymond P Perez, Denise Yardley, et al.Antimicrobial Agents and Chemotherapy|November 1, 2016
Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureusAdriana Renzoni, William L Kelley, Roberto R Rosato, et al.Breast Cancer Research : BCR|January 12, 2020
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancerLori J Goldstein, Raymond P Perez, Denise Yardley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast CancerDaniel Dávila-González, Dong Soon Choi, Roberto R Rosato, et al.Pageof 5